Jennison Associates LLC Neogenomics Inc Transaction History

Jennison Associates LLC

  • $162 Billion
  • Q4 2024

A detailed history of Jennison Associates LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Jennison Associates LLC holds 1,514,756 shares of NEO stock, worth $21.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,514,756
Previous 1,276,468 18.67%
Holding current value
$21.3 Million
Previous $18.8 Million 32.59%
% of portfolio
0.02%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025
BUY
$13.0 - $18.43 $3.1 Million - $4.39 Million
238,288 Added 18.67%
1,514,756 $25 Million
Q3 2024

Nov 08, 2024
BUY
$13.4 - $17.73 $764,349 - $1.01 Million
57,041 Added 4.68%
1,276,468 $18.8 Million
Q2 2024

Aug 05, 2024
BUY
$13.01 - $15.77 $2.18 Million - $2.65 Million
167,800 Added 15.96%
1,219,427 $16.9 Million
Q1 2024

May 02, 2024
BUY
$14.06 - $16.79 $6.47 Million - $7.72 Million
460,071 Added 77.77%
1,051,627 $16.5 Million
Q4 2023

Feb 01, 2024
BUY
$11.67 - $20.73 $1.04 Million - $1.85 Million
89,473 Added 17.82%
591,556 $9.57 Million
Q3 2023

Oct 31, 2023
BUY
$12.15 - $17.85 $6.1 Million - $8.96 Million
502,083 New
502,083 $6.18 Million
Q4 2021

Feb 08, 2022
SELL
$30.49 - $48.49 $9.18 Million - $14.6 Million
-301,226 Closed
0 $0
Q3 2021

Nov 09, 2021
SELL
$41.66 - $52.52 $6.75 Million - $8.51 Million
-162,018 Reduced 34.97%
301,226 $14.5 Million
Q2 2021

Aug 12, 2021
SELL
$36.62 - $51.69 $531,795 - $750,642
-14,522 Reduced 3.04%
463,244 $20.9 Million
Q1 2021

May 11, 2021
SELL
$41.56 - $59.88 $2.6 Million - $3.74 Million
-62,516 Reduced 11.57%
477,766 $23 Million
Q4 2020

Feb 05, 2021
BUY
$36.08 - $56.47 $4.78 Million - $7.48 Million
132,470 Added 32.48%
540,282 $29.1 Million
Q3 2020

Nov 04, 2020
BUY
$33.26 - $40.48 $402,878 - $490,334
12,113 Added 3.06%
407,812 $15 Million
Q2 2020

Aug 06, 2020
BUY
$24.21 - $31.02 $8.85 Million - $11.3 Million
365,352 Added 1203.91%
395,699 $12.3 Million
Q1 2020

May 06, 2020
SELL
$20.5 - $34.53 $203,216 - $342,295
-9,913 Reduced 24.62%
30,347 $838,000
Q2 2019

Aug 06, 2019
BUY
$19.57 - $24.1 $7,456 - $9,182
381 Added 0.96%
40,260 $0
Q1 2019

May 10, 2019
SELL
$12.14 - $20.46 $93,465 - $157,521
-7,699 Reduced 16.18%
39,879 $816,000
Q4 2018

Feb 06, 2019
BUY
$11.24 - $18.5 $49,624 - $81,677
4,415 Added 10.23%
47,578 $600,000
Q3 2018

Nov 08, 2018
SELL
$12.5 - $15.38 $7,162 - $8,812
-573 Reduced 1.31%
43,163 $663,000
Q2 2018

Aug 02, 2018
BUY
$7.99 - $14.05 $55,035 - $96,776
6,888 Added 18.69%
43,736 $573,000
Q1 2018

Apr 20, 2018
BUY
$7.23 - $8.76 $266,411 - $322,788
36,848 New
36,848 $301,000

Others Institutions Holding NEO

# of Institutions
296
Shares Held
125M
Call Options Held
698K
Put Options Held
116K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.77B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email